After Glaxo, Six Questions Your Compliance Team Needs To Ask

Chinese officials are investigating what they say is an on-going multimillion dollar pattern of bribery by GlaxoSmithKline. Based on what’s being alleged, there are already some clear lessons for companies and their overseas risk management compliance teams. Here is a short list, in the form of six questions designed to ferret out corruption.